Funds managed by Oaktree Capital Management are to invest USD150 million in Draslovka, providing preferred equity capital to support the growth of the Czech Republic-based family-owned CN-based specialty chemicals firm.
Funds managed by Oaktree Capital Management are to invest USD150 million in Draslovka, providing preferred equity capital to support the growth of the Czech Republic-based family-owned CN-based specialty chemicals firm.
Draslovka has also completed the acquisition of Australia based Mining & Process Solutions (MPS), a business that owns the exclusive rights to the Glycine Leaching process, an environmentally benign hydrometallurgical process to leach base and precious metal oxide, mixed oxide and sulphide ores.
Oaktree’s investment in Draslovka follows the Company’s recent acquisitions of Chemours’ Mining Solutions business, completed in December 2021 with the integration process currently well underway, and exceeding initial expectations, as well as the agreement to purchase Sasol South Africa Limited’s Sodium Cyanide business.
